专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

11. 发明授权

US09133392B2 Garnet material, method for its manufacturing and radiation-emitting component comprising the garnet material 有权
标题翻译：石榴石材料，其制造方法和包含石榴石材料的辐射发射部件
公开(公告)号：US09133392B2
公开(公告)日：2015-09-15
申请号：US12841989
申请日：2010-07-22
申请人： Madis Raukas , Karl Krister Bergenek , George C. Wei , Nathan M. Zink , Stefan Lange
发明人： Madis Raukas , Karl Krister Bergenek , George C. Wei , Nathan M. Zink , Stefan Lange
IPC分类号： C09K11/77 , H01J1/62 , H01J63/04 , C04B35/44
CPC分类号： C09K11/7774 , C04B35/44 , C04B2235/3215 , C04B2235/3217 , C04B2235/3222 , C04B2235/3224 , C04B2235/3229 , C04B2235/5436 , C04B2235/6582 , C04B2235/764 , C04B2235/77 , C04B2235/9646 , G02B1/00 , G02B5/20 , H01L2224/48091 , H01L2224/48247 , H01L2924/00014
摘要： A material, comprising a garnet having the composition represented by the formula A3-xB5O12:Dx and a barium-containing oxide. In the garnet A3-xB5O12:Dx, A is selected from lutetium, yttrium, gadolinium, terbium, scandium, another rare earth metal or mixtures thereof. B is selected from aluminum, scandium, gallium, indium, boron or mixtures thereof. D is at least one dopant selected from chromium, manganese and rare earth metals, particularly cerium, praseodymium or gadolinium. The dopant is present with x is 0≦x≦2.
摘要翻译：一种材料，其包含具有由式A3-xB5O12：Dx表示的组成的石榴石和含钡氧化物。在石榴石A3-xB5O12：Dx中，A选自镥，钇，钆，铽，钪，另一稀土金属或其混合物。 B选自铝，钪，镓，铟，硼或其混合物。 D是选自铬，锰和稀土金属，特别是铈，镨或钆中的至少一种掺杂剂。存在掺杂剂，其中x为0＆nlE; x＆nlE; 2。

12. 发明授权

US09000125B2 Approach to treat intraocular hypertension 有权
公开(公告)号：US09000125B2
公开(公告)日：2015-04-07
申请号：US13469838
申请日：2012-05-11
申请人： Hans-Arne Hansson , Stefan Lange , Eva Jennische
发明人： Hans-Arne Hansson , Stefan Lange , Eva Jennische
IPC分类号： C07K7/06 , A61K38/17
CPC分类号： A61K38/1709
摘要： The present invention relates to the use of antisecretory factors, such as antisecretory proteins, homologues, derivatives and/or fragments thereof having antisecretory activity, for the manufacture of a pharmaceutical composition for use in the treatment and/or prevention of intraocular hypertension. The invention thus relates to the use of pharmaceutical compositions comprising antisecretory factors in the treatment and/or prevention of intraocular hypertension, which is preferably characterized by hampered outflow of body fluid resulting in elevated pressure in the eye. The invention provides for a novel approach for treating and/or preventing such a condition turning the intraocular pressure to an acceptable level, optionally 21 mm Hg, or less.

13. 发明授权

US08487074B2 Modulation of lipid rafts 有权
公开(公告)号：US08487074B2
公开(公告)日：2013-07-16
申请号：US12289390
申请日：2008-10-27
申请人： Hans-Arne Hansson , Stefan Lange
发明人： Hans-Arne Hansson , Stefan Lange
IPC分类号： C07K14/00
CPC分类号： A61K38/1709 , A61K38/08
摘要： The present invention relates to the use of an antisecretory protein, derivative, homologue, and/or fragment thereof, having equivalent activity, and/or a pharmaceutically active salt thereof, for the manufacture of a pharmaceutical composition and/or a medical food for the treatment and/or prevention of dysfunction, e.g. abnormal function, hypo- or hyper-function of lipid rafts, receptors and/or caveolae. A dysfunction of lipid rafts, receptors and/or caveolae may be caused by or be a cause of a variety of other conditions, which are also encompassed by the present invention, such as vascular, and lung dysfunctions, and/or endocrine disorders, e.g. diabetes and related disorders. Furthermore, the invention relates to a method for the treatment and/or prevention of dysfunction of lipid rafts and/or caveolae in a mammal in need thereof.

14. 发明授权

US08207296B2 Approach to treat intraocular hypertension 有权
标题翻译：治疗眼内高血压的方法
公开(公告)号：US08207296B2
公开(公告)日：2012-06-26
申请号：US12289388
申请日：2008-10-27
申请人： Hans-Arne Hansson , Stefan Lange , Eva Jennische
发明人： Hans-Arne Hansson , Stefan Lange , Eva Jennische
IPC分类号： C07K7/06
CPC分类号： A61K38/1709
摘要： The present invention relates to the use of antisecretory factors, such as antisecretory proteins, homologues, derivatives and/or fragments thereof having antisecretory activity, for the manufacture of a pharmaceutical composition for use in the treatment and/or prevention of intraocular hypertension. The invention thus relates to the use of pharmaceutical compositions comprising antisecretory factors in the treatment and/or prevention of intraocular hypertension, which is preferably characterized by hampered outflow of body fluid resulting in elevated pressure in the eye. The invention provides for a novel approach for treating and/or preventing such a condition turning the intraocular pressure to an acceptable level, optionally 21 mm Hg, or less.
摘要翻译：本发明涉及具有抗分泌活性的抗分泌蛋白，同系物，衍生物和/或片段等抗分泌因子在制备用于治疗和/或预防眼内高血压的药物组合物中的应用。因此，本发明涉及包含抗分泌因子的药物组合物在治疗和/或预防眼内高血压中的用途，其优点在于体内流体受阻的流出，导致眼压升高。本发明提供了一种用于治疗和/或预防这种将眼内压转换成可接受水平（可选地为21mm Hg或更小）的病症的新方法。

15. 发明申请

US20090162296A1 Approach to treat intraocular hypertension 有权
标题翻译：治疗眼内高血压的方法
公开(公告)号：US20090162296A1
公开(公告)日：2009-06-25
申请号：US12289388
申请日：2008-10-27
申请人： Hans-Arne Hansson , Stefan Lange , Eva Jennische
发明人： Hans-Arne Hansson , Stefan Lange , Eva Jennische
IPC分类号： A61K9/12 , A61K38/08 , A61K38/10 , A61K38/17 , C07K7/06
CPC分类号： A61K38/1709
摘要： The present invention relates to the use of antisecretory factors, such as antisecretory proteins, homologues, derivatives and/or fragments thereof having antisecretory activity, for the manufacture of a pharmaceutical composition for use in the treatment and/or prevention of intraocular hypertension. The invention thus relates to the use of pharmaceutical compositions comprising antisecretory factors in the treatment and/or prevention of intraocular hypertension, which is preferably characterized by hampered outflow of body fluid resulting in elevated pressure in the eye. The invention provides for a novel approach for treating and/or preventing such a condition turning the intraocular pressure to an acceptable level, optionally 21 mm Hg, or less.
摘要翻译：本发明涉及具有抗分泌活性的抗分泌蛋白，同系物，衍生物和/或片段等抗分泌因子在制备用于治疗和/或预防眼内高血压的药物组合物中的应用。因此，本发明涉及包含抗分泌因子的药物组合物在治疗和/或预防眼内高血压中的用途，其优点在于体内流体受阻的流出，导致眼压升高。本发明提供了一种用于治疗和/或预防这种将眼内压转换成可接受水平（可选地为21mm Hg或更小）的病症的新方法。

16. 发明授权

US06537588B1 Food-induced antisecretory proteins in egg yolk 有权
标题翻译：蛋黄中食物诱导的抗分泌蛋白
公开(公告)号：US06537588B1
公开(公告)日：2003-03-25
申请号：US09868172
申请日：2001-07-06
申请人： Stefan Lange , Leif Göransson , Ivar Lönnroth
发明人： Stefan Lange , Leif Göransson , Ivar Lönnroth
IPC分类号： A61K3554
CPC分类号： A23G9/38 , A21D13/80 , A23K10/14 , A23K10/30 , A23K50/40 , A23K50/60 , A23K50/75 , A23L15/00 , A23L15/20 , A61K35/57
摘要： The invention generally relates to the use of natural anti-secretory proteins (NASP) for the preparation of NASP-enriched functional food products or pharmaceutical products for the treatment and prophylaxis of disease-like conditions caused by extreme body fluid discharge. In particular, the invention relates to the use of NASP-enriched egg yolk as source of NASP.
摘要翻译：本发明一般涉及天然抗分泌蛋白（NASP）用于制备富含NASP的功能食品或药物制品，用于治疗和预防由极端体液排出引起的疾病状况。特别地，本发明涉及使用富含NASP的蛋黄作为NASP的来源。

17. 发明授权

US5296243A Process to correct and optimize the composition of feed 失效
标题翻译：纠正和优化饲料组成的过程
公开(公告)号：US5296243A
公开(公告)日：1994-03-22
申请号：US854632
申请日：1992-08-13
申请人： Stefan Lange , Ivar Lonnroth , Kjell Martinsson , Leif Goransson
发明人： Stefan Lange , Ivar Lonnroth , Kjell Martinsson , Leif Goransson
IPC分类号： A23K1/00 , A23K1/16 , A23K1/18 , A61K31/045 , A61K31/047 , A61K31/16 , A61K31/195 , A61K31/70 , A61K38/16 , A61K38/36 , A61P15/00 , A61P43/00
CPC分类号： A23K50/60 , A23K20/105 , A23K20/142 , A23K20/163 , A23K50/00 , A23K50/75 , Y10S426/807
摘要： The subject of the invention is a process to correct and optimise the feed-composition on basis of testing the levels of so called FIL-lectines in the blood. This correction is exerted by adding certain sugars and amino acids to the feed. Hereby the FIL-level may be adjusted in order to optimize the growth.
摘要翻译： PCT No.PCT / SE91 / 00003 Sec。 371日期：1992年8月13日 102（e）日期1992年8月13日PCT 1991年1月3日PCT PCT。公开号WO91 / 09536 日期1991年7月11日。本发明的主题是基于测试血液中所谓的FIL-凝集素的水平来校正和优化饲料组合物的方法。这种校正通过向饲料中加入某些糖和氨基酸来发挥。因此，可以调整FIL级别以优化增长。

18. 发明申请

US20130234733A1 CAPACITIVE SENSOR ARRANGEMENT FOR SWITCHING A DOOR OPENING ON A MOTOR VEHICLE 有权
标题翻译：用于切换电动车辆上的门的电容式传感器布置
公开(公告)号：US20130234733A1
公开(公告)日：2013-09-12
申请号：US13880639
申请日：2011-08-29
申请人： Stefan Lange
发明人： Stefan Lange
IPC分类号： G01R1/02
CPC分类号： G01R1/02 , B60R25/2045 , B60R25/2054 , B60R25/246 , E05F15/00 , E05F15/73 , E05Y2400/852 , E05Y2400/858 , E05Y2900/546 , H03K17/955 , H03K2217/94052 , H03K2217/96078
摘要： A sensor arrangement for sensing movement gestures on a motor vehicle with a capacitive sensor arrangement and at least one control and evaluation device which is coupled to the sensor arrangement and which senses a change in the capacitance of the sensor arrangement with respect to a reference potential. A user can use a part of his body, for example his foot, to make a gesture in the sensing range of the sensors for activating a tailgate. At least two sensor electrode arrangements are arranged at spatially offset positions on the motor vehicle. The sensor electrodes are embodied as elongate electrode arrangements and are arranged with the same spatial orientation. One of the sensor electrodes is longer than the other. The relatively long sensor electrode extends beyond the relatively short sensor electrode on both sides in the longitudinal direction.
摘要翻译：一种传感器装置，用于利用电容式传感器装置来感测机动车辆上的移动手势，以及至少一个耦合到传感器装置并且感测传感器装置相对于参考电位的电容变化的控制和评估装置。用户可以使用他的身体的一部分，例如他的脚，在传感器的感测范围内进行手势，以激活尾门。至少两个传感器电极布置在机动车辆上的空间偏移位置。传感器电极被实施为细长电极布置并且以相同的空间取向布置。传感器电极之一比另一个长。相对较长的传感器电极在纵向两侧延伸超过相对短的传感器电极。

19. 发明申请

US20120093716A1 USE OF ANTISECRETORY FACTORS (AF) FOR OPTIMIZING CELLULAR UPTAKE 有权
标题翻译：使用抗真菌因子（AF）优化细胞摄取
公开(公告)号：US20120093716A1
公开(公告)日：2012-04-19
申请号：US13148878
申请日：2010-02-11
申请人： Eva Jennische , Stefan Lange , Hans-Arne Hansson
发明人： Eva Jennische , Stefan Lange , Hans-Arne Hansson
IPC分类号： A61K38/17 , G01N33/567 , A61K51/00 , C40B30/00 , A61P25/00 , A61P35/00 , A61P31/12 , A61P31/00 , A61P29/00 , A61P33/00 , C07K14/47 , C12Q1/48
CPC分类号： A61K38/1709 , A61K45/06 , G01N2333/91215
摘要： The present invention relates to the use of an antisecretory factor (AF) protein, peptide, derivative, homologue, and/or fragment thereof, having equivalent functional activity, and/or a pharmaceutically active salt thereof, for optimizing delivery and cellular uptake of a pharmaceutical substance and/or formulation, or a gene delivery. Typically, said pharmaceutical substance and/or formulation comprises an anticancer drug, radiation therapy, an antibiotic substance, an antiviral substance or a drug targeting posttraumatic injury, neurodegeneration, a parasite, or an inflammatory condition.
摘要翻译：本发明涉及具有相同功能活性的抗分泌因子（AF）蛋白，肽，衍生物，同系物和/或其片段，和/或其药物活性盐的用途，用于优化递送和细胞摄取药物和/或制剂，或基因递送。通常，所述药物和/或制剂包含抗癌药物，放射治疗剂，抗生素物质，抗病毒物质或靶向创伤后损伤的药物，神经变性，寄生虫或炎性病症。

20. 发明授权

US06863903B2 Pharmaceutical product comprising anti-secretory protein from egg yolk 有权
标题翻译：含有来自蛋黄的抗分泌蛋白质的药物制品
公开(公告)号：US06863903B2
公开(公告)日：2005-03-08
申请号：US10359589
申请日：2003-02-07
申请人： Stefan Lange , Leif Göransson , Ivar Lönnroth
发明人： Stefan Lange , Leif Göransson , Ivar Lönnroth
IPC分类号： A23K1/16 , A21D13/08 , A23G9/32 , A23G9/38 , A23G9/44 , A23G9/52 , A23K1/14 , A23K1/165 , A23K1/18 , A23L1/30 , A23L1/305 , A23L1/32 , A61K35/54 , A61K38/00 , A61P1/12 , A61P7/00
CPC分类号： A23G9/38 , A21D13/80 , A23K10/14 , A23K10/30 , A23K50/40 , A23K50/60 , A23K50/75 , A23L15/00 , A23L15/20 , A61K35/57
摘要： The invention generally relates to the use of natural anti-secretory protein (NASP) for the preparation of NASP-enriched functional food products or pharmaceutical products for the treatment and prophylaxis of disease-like conditions caused by extreme body fluid discharge. In particular, the invention relates to the use of NASP-enriched egg yolk as a source of NASP.
摘要翻译：本发明一般涉及天然抗分泌蛋白（NASP）用于制备富含NASP的功能性食品或药物制品，用于治疗和预防由极端体液排出引起的疾病状况。特别地，本发明涉及使用富含NASP的蛋黄作为NASP的来源。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式